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Rintangan antelmintik telah dilaporkan dalam hampir semua spesies parasit 
ternakan dan melibatkan semua kelas utama spektrum luas dadah antelmintik 
termasuk ivermektin. Oleh kerana kajian rintangan ivermektin dalam nematod parasit 
adalah terhad, maka, Caenorhabditis elegans yang hidup bebas telah digunakan 
sebagai sistem model dalam kajian ini. Ujian kepekaan ivermektin telah dijalankan 
untuk menyiasat tindak balas strain C. elegans N2 yang jenis liar kepada pendedahan 
ivermektin. Enam ujian in vitro telah dijalankan; ujian penetasan telur, ujian 
perkembangan larva, ujian membiak, ujian gerakan, ujian motiliti, dan ujian 
pengepaman faring dengan strain C. elegans DA1316 yang rintang IVM sebagai 
kawalan. Keputusan menunjukkan bahawa ivermektin adalah berkesan pada larva 
tetapi tidak pada telur strain C. elegans N2 yang jenis liar. Ivermektin menghalang 
perkembangan larva, perilaku pengeluaran telur, gerak alih, dan perilaku pemakanan 
oleh strain C. elegans N2 yang jenis liar. Berikutan ujian kepekaan ivermektin, 
pendekatan proteomik telah dijalankan bagi mengenal pasti kemungkinan ekspresi 
protein yang diatur naik dan diatur turun oleh strain C. elegans N2 yang jenis liar 
kepada pendedahan ivermektin. Gel elektroforesis dua dimensi telah dijalankan 
untuk membandingkan peta protein antara strain C. elegans N2 yang rintang IVM 
(kumpulan rawatan)  dan strain C. elegans N2 yang jenis liar (kumpulan kawalan). 
Antara 25 tompok protein yang dipilih, 18 tompok protein telah diatur naik dan tujuh 
tompok protein telah diatur turun dalam kumpulan rawatan berbanding kumpulan 
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kawalan. Analisis selanjutnya oleh spektrometri jisim MALDI-TOF telah mengenal 
pasti 12 protein daripada 18 tompok protein yang diatur naik dan satu protein 
daripada tujuh tompok protein yang diatur turun. Protein yang diatur naik terdiri 
daripada protein kejutan haba 70 kDa A, calreticulin, aktin-2, aktin-3, aktin-4, ATP 
sintase subunit alpha, ATP sintase subunit beta, kemungkinan jenis proton V ATPase 
subunit B, kemungkinan kinase arginin, faktor permulaan transkripsi IIB, 
adenosylhomocysteinase, dan vitelogenin. Protein yang diatur turun adalah 
kemungkinan S- adenosylmethionine sintase. Protein ini; yang terlibat dalam caperon 
molekular, motiliti sel, metabolisma dan penghasilan tenaga, ungkapan regulasi gen, 
penyimpanan lipid, dan sebagai protein prekursor; mungkin berkaitan dengan 
rintangan ivermektin yang diperolehi oleh C. elegans. Sebagai penemuan asas untuk 
mekanisme penyesuaian dan perlindungan oleh C. elegans untuk mempertahankan 
terhadap ancaman alam sekitar dan kerosakan selular, kajian ini akan membantu 
menyampaikan peranan sistem saraf dan laluan tambahan untuk meneroka rawatan 
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Anthelmintic resistance has been reported in almost all species of parasites of 
livestock and involved all the major classes of broad-spectrum anthelmintic drug 
including ivermectin. Due to the study of ivermectin resistance in parasitic nematode 
is limited, thus, a free-living Caenorhabditis elegans was used as a model system in 
this study. The ivermectin sensitivity assay was carried out to investigate the 
response of wild-type C. elegans N2 strain to ivermectin exposure.  Six in vitro 
assays were conducted; egg hatch assay, larval development assay, reproduce assay, 
thrashing assay, motility assay and pharyngeal pumping assay with IVM-resistant 
C. elegans DA1316 strain as a control. The results showed that ivermectin is 
effective on larvae but not on the eggs of wild-type C. elegans N2 strain. Ivermectin 
inhibits the larval development, egg-laying behavior, locomotion and feeding 
behavior of wild-type C. elegans N2 strain. Following the ivermectin sensitivity 
assay, the proteomic approach was carried out to identify the possible up-regulated 
and down-regulated protein expression of wild-type C. elegans N2 strain to 
ivermectin exposure. Two-dimensional gel electrophoresis was performed to 
compare the protein maps of the IVM-resistant C. elegans N2 strain (treated group) 
and wild-type C. elegans N2 strain (control group). Among the 25 selected protein 
spots, 18 protein spots were up-regulated and seven protein spots were down-
regulated in the treated group compared to the control group. A subsequent analysis 
by MALDI-TOF mass spectrometry has identified 12 proteins of the 18 up-regulated 
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protein spots and a protein of the seven down-regulated protein spots. The up-
regulated proteins consist of heat shock 70 kDa protein A, calreticulin, actin-2, actin-
3, actin-4, ATP synthase subunit alpha,  ATP synthase subunit beta, probable V-type 
proton ATPase subunit B, probable arginine kinase, transcription initiation factor 
IIB, adenosylhomocysteinase, and vitellogenin. The down-regulated protein is 
probable S-adenosylmethionine synthase. These proteins; which are involved in 
molecular chaperone, cell motility, metabolism and energy production, gene 
regulation expression, lipid storage, and as a precursor protein; might be related in 
the acquired ivermectin resistance in the C. elegans. As a fundamental discovery for 
adaptive and protective mechanisms in C. elegans to defend against the 
environmental threat and cellular damage, this study will help to cast light on the role 
of the nervous system and the additional pathways to explore for the treatment of 








The livestock industry is a significant factor in the agricultural sector in 
Malaysia. It provides employment opportunities and producing food sources of 
animal protein for the population. This industry can be classified into two sectors 
which are ruminant and non-ruminant. The non-ruminant sector such as poultry and 
swine has been able to commercial and efficient in production (Ariff et al., 2015). 
However, the ruminant sector such as buffalo, cattle, goat, and sheep is not well 
production explored in which the production is less than demand and need to be 
imported from abroad (Jamaludin et al., 2014; Ariff et al., 2015). 
There are many factors affect the livestock production and productivity, 
which are climate changes, health aspects, and nutrition supply (Thornton, 2010; 
Lamy et al., 2012).  However, the factor that gives most impact on the livestock 
production is the health aspects involving diseases and parasites such as 
helminthiasis and pneumonia (Chandrawathani et al., 2009). The livestock usually 
gets infected with parasitic nematode through the free contact with their eggs or 
larvae (Bethony et al., 2006). These parasites live and reproduce by sucking the 
nutrient in the livestock and causes the animal getting sick, lose weight, and decrease 
in production and productivity (Florian et al., 2013). It caused direct loss to farmers 
due to decline in production and death of livestock (Jabbar et al., 2006).  
The used of chemotherapy agent such as anthelmintic drug was managed to 
minimise these infections for a while. However, a new problem has emerged because 
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the parasitic nematodes have become resistant to the anthelmintic drug. The 
resistance is said to be developed when the previously effective drug is no longer kill 
the parasitic population at the therapeutically recommended dosages (Jackson, 1993).  
The resistance has been reported in nematode parasites of almost all species of 
livestock and included all the major classes of broad-spectrum anthelmintic drug 
(Jabbar et al., 2006). In Malaysia, the frequently used of the drugs with no control 
has triggered the emergence of drug resistance in the small ruminant population 
(Chandrawathani and Nurulaini, 2012).  
In order to maintain anthelmintic drug efficacy, it is essential to disclose the 
mechanism of action of the drug and the molecular mechanism employed by the 
parasitic nematode that results in resistance. The development of molecular-based 
test gives the opportunity to understand the mechanisms of anthelmintic adaptation in 
parasitic nematode that turn into resistance. This study is focused on ivermectin drug 
as it remains a major global anthelmintic (Crump and Omura, 2011). Moreover, the 
study of ivermectin resistance in parasitic nematode is very limited due to the 
complex life cycle of parasitic nematode and also the lack of appropriate functional 
genomic assay  (Jones et al., 2005; Britton and Murray, 2006; Holden-Dye and 
Walker, 2007). Thus, the Caenorhabditis elegans was used as a model organism for 
the parasitic nematode as they share some physiological and pharmacological 
characteristics (Geary and Thompson, 2001; Jones et al., 2005; Britton and Murray, 
2006; Holden-Dye and Walker, 2007).  
Ivermectin kills the C. elegans at the therapeutic concentration that making 
the C. elegans as a useful model system to examine the mechanism of ivermectin 
toxicity and resistance (Dent et al., 2000). The data from this study will expand our 
understanding of how cellular remodeling might occur in C. elegans to ivermectin 
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stress response and the survival of C. elegans at the protein level. 
 
1.1 Research objectives 
The objectives of this study are as follows: 
i. To investigate the response of C. elegans to ivermectin exposure. 
ii. To identify the possible up-regulated and down-regulated protein expression 











2.1 Livestock industry in Malaysia 
 Agriculture is one of the main contributors to the Malaysian economy. This 
sector contributed 8.9% (RM94.1 billion) to the Gross Domestic Product (GDP) in 
2015 (Department of Statistics Malaysia, 2016) and showed an increased about 1.2% 
from previous year (Department of Statistics and Ministry of Finance Malaysia, 
2016). Of the total, 10.7% was from the livestock industry which consists of poultry 
meat, chicken/duck egg, cattle milk, beef, mutton and swine (Department of 
Statistics Malaysia, 2016). According to Department of Veterinary Services (2016), 
the production of poultry meat, chicken/duck egg, and cattle milk showed an 
increased in 2015 about 2.6%, 6.5%, and 0.9% compared to the previous year, 
however, the production of beef, mutton, and swine showed a decreased about 4.5%, 
2.2%, and 0.8%. The poultry meat and chicken/duck egg recorded self-sufficiency 
ratio more than 100%  which is  104.5% and 116.7%, while the beef, mutton, swine 
and cattle milk recorded self-sufficiency ratio less than 100% which is 23.5%, 
11.5%, 94.6% and 7.0% (Department of Veterinary Services, 2016). The slower 
growth of production and higher growth of consumption is probably the cause of the 





2.2 The parasitic nematodes of livestock 
Nematodes are typically worm-like which have a body that is long, narrow 
and threadlike, except they are un-segmented (Kiontke and Fitch, 2013). They are 
simple in body plan, lacking appendages and colorless (Kiontke and Fitch, 2013). 
Basically, the body form is similar to a flexible cylinder with a rounded head and a 
pointed tail. They have been characterized as a tube within a tube because of the 
alimentary canal which extends from the mouth on the anterior end to the anus 
located near the tail (Kiontke and Fitch, 2013). They possess the digestive, nervous, 
excretory and reproductive systems but lack a discrete circulatory or respiratory 
system (Kiontke and Fitch, 2013). They move by contraction of the dorsal and 
ventral longitudinal muscles which is thrashing back and forth, and at least a film of 
water is required for dynamic movement (Kiontke and Fitch, 2013). 
Many of them are free-living and play critical ecological roles as decomposer 
and predator on microorganisms (Blaxter et al., 1998; Dorris et al., 1999). However, 
there are also including parasitic species which are cause diseases on animals, plants 
and humans such as roundworms, hookworms, trichina, pinworms and filarial worms 
(Blaxter et al., 1998; Dorris et al., 1999). These species can be distinguished by the 
body size and feeding structure (Kiontke and Fitch, 2013). The bacterial-feeding 
nematodes have no teeth or stylet like the plant-feeding nematodes that have a 
hypodermic needle-like stylet to puncture plant cell walls and ingest food 
(Kiontke and Fitch, 2013). While the predatory nematodes have large teeth to slice 
open their prey (Kiontke and Fitch, 2013) and the parasitic nematodes have large 
hook-like teeth (Blaxter and Koutsovoulos, 2015). Most of them are microscopic in 
size, however, some species that parasite to animals are much larger and can grow to 
several centimeters in length (Dorris et al., 1999). Their sizes are the range in 0.2 mm 
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to over 6 meters depends on species (Blaxter and Koutsovoulos, 2015).  
Nematodes are the most abundant type of animal on earth and can be found in 
most habitats; within or on host animals and plants, from the Arctic ice to the hot 
springs (Coghlan, 2005; Kiontke and Fitch, 2013; Blaxter and Koutsovoulos, 2015). 
There are nearly 30, 000 described species have been classified in the phylum 
Nematoda (Kiontke and Fitch, 2013). Scientific classification of Nematoda is shown 
in Figure 2.1. 
 
Kingdom : Animalia 
Super phylum : Ecdysozoa 
Clade  : Cycloneuralia 
Phylum : Nematoda 
Figure 2.1: Scientific classification of Nematoda. 
 
Nematoda is divided into two classes, namely Secernentea and Adenophorea 
(Blaxter et al., 1998; Dorris et al., 1999). Secernentea includes a parasitic and free-
living group in terrestrial habitats, while Adenophorea includes a wide range of 
marine, freshwater and soil nematodes (Dorris et al., 1999). Five major clades are 
identified in phylum Nematoda (Blaxter et al., 1998; Dorris et al., 1999). Two major 
clades (I and II) are found within Adenophorea and three major clades (III, IV, and 
V) are found within Secernentea (Blaxter et al., 1998; Dorris et al., 1999). Figure 2.2 
shows the phylogenetic structure of the phylum Nematoda. Clade I groups the 
vertebrate-parasitic order Trichocephalida, the insect-parasitic order Mermithida, 
the plant-parasitic order Dorylaimida and the free-living order Mononchida 






Figure 2.2: The phylogenetic structure of the phylum Nematoda. Five major 
clades are identified in the Nematoda and labeled I to V. (Source: 





Triplonchida and the free-living order Enoplida (Blaxter et al., 1998). Clade III 
groups the vertebrate-parasitic from orders Ascaridida, Spirurida, and Oxyurida with 
the arthropod-parasitic order Rhigonematida (Blaxter et al., 1998; Dorris et al., 
1999). Clade IV groups the plant-parasitic from orders Tylenchida and Aphelenchida, 
the vertebrate-parasitic order Strongyloididae, the insect-parasitic order 
Steinernematidae and the free-living from orders Cephalobidae and Panagrolaimidae 
(Blaxter et al., 1998; Dorris et al., 1999). The last clade, clade V, groups the free-
living order Rhabditina, the vertebrate-parasitic order Strongylida and the insect-
parasitic order Diplogasterida (Blaxter et al., 1998; Dorris et al., 1999). 
In phylum Nematoda, five orders are free-living nematodes, four orders are 
parasites on plants and ten orders are parasites on animals (Blaxter et al., 1998; 
Dorris et al., 1999). The animal-parasitic nematodes are parasites for humans, 
domestic animals, and wildlife (Blaxter et al., 1998; Dorris et al., 1999). The animal-
parasitic nematodes are often characterized in a larger group as helminths which 
consist of nematodes, cestodes, and trematodes (James et al., 2009). They are a major 
limiting factor in livestock sector worldwide. Their infections on livestock cause 
significant economic losses. These parasitic nematodes have the ability to survive the 
immunological attack and can live in an infected individual for years 
(Coghlan, 2005).They reduce weight gain and productivity in meat, milk, and wool, 
incur the cost for anthelmintic treatments, and cause animal mortality (Sissay et al., 
2007). However, the impact of the infection depends on the type of host species, the 
pathogenicity of the parasite species, the host and parasite interaction, and the 
infective dose (Over et al., 1992).  
 Livestock usually infected with gastrointestinal nematodes. In small 
ruminants like sheep and goats, the major parasitic nematode which frequently 
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reported is from family Trichostrongylidae such as Haemonchus contortus, 
Teladorsagia circumcincta and Trichostrongylus colubriformis (Waller, 2006; 
Roeber et al., 2013). In large ruminants like cattle and horses, the parasitic nematode 
species mostly detected is such as Ostertagia spp., Cooperia spp., Bunostomum spp., 
Strongyloides papillosus, Oesophagostomum spp., and Trichostrongylus axei (De 
Graef et al., 2013; Roeber et al., 2013). Ostertagia spp. and Cooperia spp. represent 
important pathogenic genera, and when they are present in the large numbers, they 
can cause serious losses. These gastrointestinal nematodes infections are associated 
with poor farm management, ingestion of contaminated food and water, nutritional 
deficiencies, age of the ruminants and the climate (Gwaze et al., 2009; Mat Yusof 
and Md Isa, 2016). 
 Infestation with parasitic nematodes is generally termed as helminthiasis. All 
species of animals can be infected with parasitic nematodes; however, the infection is 
worst in the very young and the very old animals (Bamaiyi, 2012). Helminthiasis can 
cause mortality and morbidity (Norakmar et al., 2010; Nor-Azlina et al., 2011). 
However, the effects are dependent on the number of parasitic nematodes in the 
infected animal and the species of nematodes. Common clinical signs include weight 
loss, anemia, diarrhea, severe dehydration, reduced feed intake, lethargy, rough hair 
coat, reduced milk production, uncoordinated movement and reduced growth. 
Untreated severe cases can lead to death. 
Haemonchus contortus, a bloodsucker nematode, is the most important 
parasite infecting small ruminant in Malaysia and the second most important cause of 
mortalities in goat and sheep of all ages mostly in poorly managed farms (Sani et al., 
2004; Chandrawathani et al., 2009; Norakmar et al., 2010). Chandrawathani et al. 
(1999) reported that H. contortus had predominated the goats and sheep in Peninsular 
10 
 
Malaysia. Studies on the prevalence of parasitic infestation of small ruminant 
reported that H. contortus as the most prevalent nematodes species infected the goats 
and sheep in Penang Island (Wahab and Adanan, 1992), Perak (Zainalabidin et al., 
2015) and Terengganu (Mat Yusof and Md Isa., 2016). They cause several subclinical 
effects on small ruminant such as growth depression, reduction in milk yield, 
hypoproteinemia, digestive inefficiency and loss of appetite (Mat Yusof and Md Isa, 
2016).  
 
2.3 The use of anthelmintic drugs against parasitic nematodes 
 The most common method used to control parasitic nematode infection in 
livestock is under treatment with anthelmintic drugs. Anthelmintic drugs are 
chemical substances that serve as an antiparasitic agent to eradicate parasitic worm 
infections from the body either in the intestine or tissues of other organs. Infections 
in the intestines are treated by the drug kill or paralyze the worms, which then 
eliminate them through the feces. Worm infections of other organs are directly killed 
by the drug to prevent them absorbing the essential nutrient from the body.  Usually, 
these drugs do not give the side effects but sometimes it causes diarrhea, headaches, 
and dizziness in several individuals.  
Phenothiazine is the first anthelmintic drug that was introduced in 1940, 
followed by piperazine in 1954 and bephenium in 1959. These drugs are effective to 
treat specific parasite species with few side effects to the host. Between 1960 and 
1980, the safer broad-spectrum drugs were introduced namely benzimidazoles, 
imidazothiazoles and macrocyclic lactones.  These drugs are more effective than the 
earlier drugs and had significantly lower dose rates (Kohler, 2001; McKellar and 






Figure 2.3: Chemical structure of anthelmintic drugs. (A) Phenothiazine 
(C12H9NS), (B) Piperazine (C4H10N2), (C) Bephenium (C17H22NO
+
), 
(D) Benzimidazole (C7H6N2), (E) Imidazothiazole (C4H3S) and (F) 
Macrocyclic lactone, ivermectin (C48H74O14).  








Benzimidazoles were introduced in 1961 started with thiabendazole, the first 
broad-spectrum anthelmintic produced, then followed by albendazole and 
fenbendazole (Kohler, 2001; Holden-Dye and Walker, 2007; De Graef et al., 2013). 
The biochemical basis of benzimidazole’s action is they bind selectively to the 
microtubule subunit protein, β-tubulin, and inhibit the microtubule formation that 
affects on locomotion and reproduction (Martin, 1997; Kohler, 2001; Jabbar et al., 
2006; Gilleard, 2006; Holden-Dye and Walker, 2007).  
After benzimidazoles, a new anthelmintic class of imidazothiazoles was 
introduced in 1970 which consists of levamisole, pyrantel, and morantel (Kohler, 
2001; Holden-Dye and Walker, 2007; De Graef et al., 2013). These drugs are 
nicotinic receptor agonists that bind to the recognition site of the excitatory nicotinic 
acetylcholine receptors on body wall muscle and cause depolarization and spastic 
muscle paralysis (Martin, 1997; Kohler, 2001; Gilleard, 2006; Jabbar et al., 2006; 
Holden-Dye and Walker, 2007).  
In 1981, the remarkable potent anthelmintic drugs, macrocyclic lactones, 
which consist of avermectins and milbemycins, were introduced into market (Kohler, 
2001; Holden-Dye and Walker, 2007). They act as an agonist of invertebrate-specific 
inhibitory chloride channels family that is activated by glutamic acid (Kohler, 2001; 
Gilleard, 2006; Jabbar et al., 2006). The binding of this drug results in irreversible 
chloride ion currents that cause depolarization of the cell membrane and muscle 
paralysis (Kohler, 2001; James et al., 2009). This group elicits a potent and persistent 
paralysis of nematode pharyngeal and body wall musculature (Martin, 1997; Holden-





2.4 Macrocyclic lactones-ivermectin as novel chemotherapeutic 
 Macrocyclic lactones are a class of anthelmintic drugs that are widely used to 
treat parasitic nematode infections in animal and human (Ardelli et al., 2009). It 
consists of two subclasses; the avermectins such as ivermectin, abamectin, 
doramectin, and eprinomectin, and the milbemycins such as MOX (Ardelli et al., 
2009). They are produced naturally by fermentation of soil-dwelling actinomycetes 
from the genus Streptomyces which was originally isolated from soil in Japan 
(Crump and Otogura, 2005). The strains of Streptomyces spp which produces 
milbemycin-type compounds are commonly found in soil samples, instead of the 
strains of Streptomyces spp which produces avermectin-type compounds are rare and 
are only produced by the strain of Streptomyces avermitilis (Vercruysse and Rew, 
2002).  
 Ivermectin was the first macrocyclic lactone developed and approved for use 
in animals (Vercruysse and Rew, 2002; Ardelli et al., 2009). It is a semi-synthetic 
derivate of a naturally occurring fermentation product, avermectin (Holden-Dye and  
Walker, 2007; Canga et al., 2009; James et al., 2009). Its chemical structure is almost 
similar to the avermectin, selectively reducing one double bond in avermectin using 
Wilkinson’s catalyst produced ivermectin (Figure 2.4) (Canga et al., 2009). This 
small change in molecular shape makes the ivermectin is more safety to host and 
more effective to fight the parasitic nematode infections (Geary, 2005; Holden-Dye 
and Walker, 2007; Liebig et al., 2010). 
After being introduced as an antiparasitic agent in 1981 by Merk and Dohme 
(Holden-Dye and Walker, 2007; Omura, 2008; Canga et al., 2009), ivermectin has 
become the mainstay of livestock parasite control (Laing et al., 2012; Demeler et al., 





Figure 2.4: Chemical structure of ivermectin. Ivermectin is a derivate of 
avermectin. Selectively reducing one double bond in avermectin using 






the last decade (Laing et al., 2012). It becomes one of the most important and 
successful anti-parasitic drug (Geary, 2005; James and Davey, 2009; Laing et al., 
2012) and widely used for the treatment of endo- and ectoparasites in human and 
animal including inserts, arthropods, and nematodes such as Onchocerca volvulus, 
Haemonchus contortus, Trichosrongylus colubriformis, Cooperia oncophora, and 
Dirofilaria immitis (Geary, 2005; Omura, 2008). In humans, ivermectin has been 
used intensively since 1987 to control endemic onchocerciasis (river blindness) 
caused by infection with the parasitic worm O. volvulus in Africa and Latin America 
(Dourmishev et al., 2005). 
Ivermectin is characterized by slow absorption process, a broad distribution 
of the organism, low metabolism and slow excretion (Canga et al., 2009). It shows 
good bioavailability and enterohepatic recycling which makes it very effective for 
the long-term (Dourmishev et al., 2005). The ivermectin accumulates in the liver, 
edible tissues and fat of the host in unaltered ivermectin form as a drug reservoir 
(Canga et al., 2009). The drug was mainly excreted in the feces and urine. Due to 
ivermectin undergoes little metabolism, most of the dose is excreted unchanged 
(Canga et al., 2009). 
 
2.5 The emergence of anthelmintic resistance 
 Anthelmintic resistance has emerged as a significant problem in the livestock 
industry. The resistance occurs when the susceptible parasite populations that 
normally affected by a given dose of the anthelminitic drug are managed to survive 
the treatment (James et al., 2009; De Graef et al., 2013). The decline in the response 
of the parasites to the anthelmintic drug can be indicated through the reduction in the 
efficacy of the drug against the population of parasites or the increasing duration of 
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treatment with requiring the additional treatments (James et al., 2009). Resistance is 
heritable (Sangster, 1999; Gilleard and Beech, 2007; De Graef et al., 2013). The 
parasites can be resistant to one or more drugs at a time. Resistance to drugs in the 
same class is known as side-resistance, whereas the resistance to two or various 
classes is known as cross-resistance and multi-drug-resistance (Sangster, 1999; 
De Graef et al., 2013).  
The anthelmintic resistance was reported is more severe in small ruminant 
than in large ruminant (Waller, 1997; De Graef et al., 2013; Shalaby, 2013). The 
parasitic nematodes of sheep and goats have reported resistance to all of the major 
classes of broad-spectrum anthelmintic drugs (Waller, 1997; James et al., 2009; 
Shalaby, 2013). In contrast, there are reports of cattle nematodes resistant to the 
range of broad-spectrum anthelmintic drugs, however, the evolution of resistance in 
these parasites is slower than in sheep and goat nematodes (Waller, 1997; Sutherland 
and Leathwick, 2011; Shalaby, 2013). The management systems that used an 
extensive grazing area and few anthelmintic treatments help in controlling and 
delaying the development of resistance in cattle nematodes (Coles, 2002; Shalaby, 
2013).  
The resistance much going on parasitic nematodes that live in sheep and 
goats (Waller, 1997) then was developed among the small and large ruminants 
(Kaplan, 2004). To date, the resistance was reported to spread rapidly among the 
parasites in most classes of livestock to all the commercially available anthelmintic 
drugs (Sangster, 1999; Gilleard and Beech, 2007). The development of resistant to 
anthelmintic drugs have been reported shortly after their introduction into the market 




Table 2.1: The development of resistance to anthelmintic drugs 




- Phenothiazine 1940 1957 
- Piperazine 1954 1966 
Benzimidazole Thiabendazole 1961 1964 
 Cambendazole 1970 1975 
 Oxibendazole 1970 1985 
 Mebendazole 1972 1975 
 Albendazole 1972 1983 
 Fenbendazole 1975 1982 
 Oxfendazole 1976 1981 
 Triclabendazole 1983 1998 
Imidazothiazole Levamisole 1970 1979 
 Pyrantel 1974 1996 
 Oxantel 1976 - 
 Morantel 1970 1979 
Macrocyclic 
lactone 
Abamectin Late 1970’s 2001 
 Ivermectin 1981 1988 
 Moxidectin 1991 1995 
 Doramectin 1993 2007 
 Eprinomectin 1996 2003 
The resistance was reported to all the commercially available anthelmintic drugs. The 
development of resistant to anthelmintic drugs was reported shortly after their 
introduction into the market. 






The anthelmintic resistance was begun in the middle of 1950s (Jabar et al., 
2006). The first reports of anthelmintic resistance were to phenothiazine in 
Haemonchus contortus of sheep (Kaplan, 2004; Jabbar et al., 2006) and then in 
cyathostomins (small strongyles) of horses (Kaplan, 2004). Phenothiazine was 
introduced to the market in 1940 and the resistant populations were reported in 1957 
(James et al., 2009; De Graef et al., 2013).  
Similar trends occurred with the classes of broad-spectrum anthelmintic 
drugs. Resistance to thiabendazole (benzimidazoles), levamisole (imidazothiazoles) 
and ivermectin (macrocyclic lactones) was reported in 1964, 1979 and 1988 after the 
drugs being introduced to the market in 1961, 1970 and 1981. The first resistance of 
thiabendazole and ivermectin were reported in H. contortus of sheep (Shoop, 1993; 
Kaplan, 2004) while the first resistance of levamisole was reported in H. contortus 
and T. colubriformis of sheep (Sangster, 1999). The resistance to all these three major 
drug classes has become a common thing nowadays (Gilleard, 2006; Pomroy, 2006; 
Sargison et al., 2007). 
 
2.6 Ivermectin resistance 
 Ivermectin resistance was first reported in South Africa in 1988, after 33 
months the drug was officially introduced to the market there and the first species 
detected resistance to this drug is Haemonchus contortus in the sheep (Shoop, 1993). 
Intensive use of ivermectin over several years has led to the widespread development 
of ivermectin resistance (Shoop, 1993; Gilleard, 2006; Laing et al., 2012). The 
resistance was developed after only a few generations of parasites were exposed to 
the drug (Coles et al., 2005). It has been spread out rapidly and was reported in a 
number of parasites including the trichostrongylid nematodes (Waller, 1999).  
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 The mechanism of ivermectin resistance is complex with alleles at several 
loci contributing to the resistance phenotype (Gilleard, 2006). Mutagenesis 
experiments have uncovered over 30 different loci that give rise to resistance but at 
relatively low levels (Starich et al., 1995). However, studies using the mutagenic 
drug treatment in the model nematode C. elegans have shown that mutations in 
subunits of glutamate-gated chloride channel receptor render worms highly resistant 
to ivermectin (Dent et al., 1997, 2000; Gilleard, 2006; Gilleard and Beech, 2007). 
These studies identified several potential genes that may be associated with 
ivermectin resistance, demonstrating that the genetics of ivermectin resistance are 
complex (Gilleard, 2006).  
 Ivermectin resistance required null mutations in three different subunits of the 
target glutamate-gated channels which are avr-14 (GluClα3), avr-15 (GluClα2) and 
glc-1 (GluClα1) (Dent et al., 2000; Gilleard, 2006). The mutation confers extremely 
high levels of resistance to ivermectin whereas mutating any two of these genes does 
not cause the resistance (Dent et al., 2000; Gilleard, 2006). However, mutating of 
only one of the channel subunits can inhibit the pharyngeal pumping of nematode 
(Dent et al., 2000; Gilleard, 2006). This is because each of these receptor subunits is 
involved in parallel pathways which is avr-15 acts in pharyngeal muscle whereas 
avr-14 and glc-1 act in neurons regulating pharyngeal function (Dent et al., 2000; 
Gilleard, 2006).  
 
2.7 Limitation study of parasitic nematodes 
Haemoncus contortus had been used as a model parasitic nematode for the 
study of anthelmintic resistance. It is one of the parasitic nematode species which is 
resistant to anthelmintic drugs and relatively closed to other important parasitic 
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nematode species in livestock  (Kaplan, 2004; Gilleard, 2006). However, being a 
parasite makes it impossible to undertake the experiment in the laboratory without 
using the artificial laboratory animal hosts (Jones et al., 2005). Parasitic nematodes 
are difficult to culture and analyze independently of their hosts (Blaxter et al., 1998). 
This is a major problem faced by researchers working on parasitic nematodes which 
is the lack of in vitro culture systems and the requirement to propagate life-cycles in 
vivo. Moreover, the studies of this parasite in their natural hosts were limited by 
ethical, time-consuming, labor-intensive and cost consideration (Gilleard, 2006; 
Wimmersberger et al., 2013). 
Most parasitic nematodes have a direct life cycle. The life cycle has two 
distinct phases; within the host and the free-living stage where the parasite is 
developing in the environment. The fertilized adult female worms in the digestive 
tract lay the eggs which are then passed in the feces onto pasture (Roeber et al., 
2013). The eggs hatch to first-stage larvae and feed on bacteria contained in the fecal 
pellet and then undergo two molts to develop to the ensheathed third-stage larvae 
(Roeber et al., 2013). The sheath protects the L3 stage from environmental 
conditions but prevents it from feeding (Roeber et al., 2013). The L3, the most 
resistant of the free-living stages, then migrates under moist conditions onto the 
pasture and need to survive until ingested by the ruminant host (Roeber et al., 2013). 
Following ingestion, the larvae undergo two more molts as L4 and L5 in the gastric 
glands before maturing into adult worms and emerge from the glands onto the 
surface of the abomasal mucosa. The adult’s mate and the female worm will then 





Apart from the complex life cycle of parasitic nematodes, another constraint 
is the study of gene function in parasitic nematodes is still limited (Gilleard, 2006). 
These parasites lack homogeneity in their parental genetic backgrounds due to the 
parental populations are likely to be highly polymorphic (Gilleard, 2006). This 
situation may lead to misleading results in the detailed analysis of cross progeny 
(Gilleard, 2006). Brugia malayi is the only parasitic nematode which essentially 
complete genome sequence is available, however full assembly and annotation have 
not been completed (Ghedin et al., 2004; Britton and Murray, 2006; Blaxter and 
Koutsovoulos, 2015).  
 Until now, the technology and genomic resources for parasitic nematode are 
still lagging behind those available for C. elegans. Even there is some recent progress 
in developing RNAi for H. contortus but there are problems for reverse genetic 
analysis in these parasites species (Gilleard, 2006) and optimization on this technique 
will be required before it can be used as a reliable functional genomics tool in 
parasitic nematodes (Britton and Murray, 2006). Given the difficulty in passaging 
parasitic nematodes, the limited success of transgenics and RNAi, and the absence or 
poorly annotated genomes of most helminths, C. elegans stay as a good alternative 
(James et al., 2009).  
 
2.8 Caenorhabditis elegans as a model organism 
Caenorhabditis elegans (Plate 2.1) is a small free-living nematode usually 
found in the temperate soil environments and feed on bacteria such as 
Escherichia coli. The name of Caenorhabditis elegans is made up of a combination 
of Greek and Latin words. Caenorhabditis is a Greek word which means recent rod-












worm was named Rhabditis elegans by Maupas in 1900 that collected it from rich 
humus soil in Algeria, North Africa. However, it was then placed in the subgenus 
Caenorhabditis by Osche in 1952 and raised to generic status by Dougherty in 1955 
(Riddle et al., 1997). Scientific classification of C. elegans taxonomy is shown in 
Figure 2.5. 
 
Kingdom : Animalia 
Phylum : Nematoda 
Class  : Chromadorea 
Order  : Rhabditida 
Family  : Rhabditidae 
Genus  : Caenorhabditis 
Species : C. elegans 
Figure 2.5: Scientific classification of C. elegans taxonomy tree. 
 
Caenorhabditis elegans has emerged as one of the most popular and well-
characterized model organisms after being introduced by Brenner in 1963 (Ankeny, 
2001; Jones et al., 2005). Table 2.2 shows the major events in C. elegans research. 
Sydney Brenner is the person who is doing research about genetics and 
developmental of C. elegans in 1974 (Ankeny, 2001) and John Sulston is the person 
that responsible for completing the cell lineage of C. elegans in 1980. The genetic 
sequence of C. elegans was essentially completed in 1998 (Ankeny, 2001;   Britton 
and Murray, 2006). The information greatly helped in the study of development and 




Table 2.2: Major events in C. elegans research 
Year Event 
1900 Organism that becomes known as C. elegans identified by Maupas. 
1948 Caenorhabditis has been proposed as the target for genetic research 
(Dougherty and Calhoun). 
1963 June: Brenner writes the letter to Perutz proposing a change in 
research direction. 
October: Brenner obtains the sample of C. elegans from Dougherty. 
1964 Brenner continuous to investigate other organisms for the project. 
1966 Genetic work on C. elegans begins at the Laboratory of Molecular 
Biology (LMB). Mutagenic agents used on worms for genetic 
studies. 
Late 1960s Neurobiological studies begun at the LMB on C. elegans. Sequence 
length determined by Brenner and Sulston. 
1974 Brenner publishes results of genetic studies on C. elegans. Post-
embryonic developmental lineages published. 
1983 Complete embryonic cell lineages published in “The Mind of a 
Worm” (nervous system wiring diagram). 
Mid 1980s Mapping of the C. elegans genome. The Human Genome Project 
formally begins: C. elegans included among the ‘model organisms’. 
1998 Genetic sequence completed. 
Source: Timeline: The natural history of C. elegans research (Ankeny, 2001). 
  
